| Scrape Result | 1962 |
|---|---|
| Id | 2,591,270 |
| Active | 1 |
| Created Epoch | 1,733,447,180 |
| Modified Epoch | 1,746,453,302 |
| Original Ad Id | 0 |
| Collationcount | 0 |
| Collationid | 0 |
| Enddate | 0 |
| Hasuserreported | 0 |
| Hiddensafetydata | 0 |
| Impressionsindex | 0 |
| Isaaaeligible | 0 |
| Isactive | 0 |
| Isprofilepage | 0 |
| Pageisdeleted | 0 |
| Creation Time | 0 |
| Page Id | 100,369,985,875,674 |
| Page Is Profile Page | 0 |
| Is Reshared | 0 |
| Version | 0 |
| Page Like Count | 400 |
| Page Is Deleted | 0 |
| Spend | 0 |
| Startdate | 0 |
| Created | 12/5/24, 7:06 PM |
| Modified | 5/5/25, 8:55 AM |
| Status | active |
| Notes | |
| Adarchiveid | |
| Currency | |
| Entitytype | |
| Fevinfo | |
| Gatedtype | |
| Hidedatastatus | |
| Impressionstext | |
| Pageid | |
| Pageinfo | |
| Pagename | |
| Reachestimate | |
| Reportcount | |
| Ad Creative Id | |
| Byline | |
| Caption | bit.ly |
| Cta Text | Learn more |
| Dynamic Versions | |
| Effective Authorization Category | |
| Display Format | VIDEO |
| Title | Understanding & Preventing FVIII Inhibitors: An Enduring HA Research Priority |
| Link Description | |
| Link Url | https://bit.ly/ghr_podlink |
| Page Welcome Message | |
| Page Name | Global Hemophilia Report |
| Page Profile Picture Url | https://scontent-iad3-2.xx.fbcdn.net/v/t39.35426-6/469384559_593063206580691_2652473784195540957_n.jpg?stp=dst-jpg_s60x60_tt6&_nc_cat=111&ccb=1-7&_nc_sid=c53f8f&_nc_ohc=57FY9hDV4RQQ7kNvgE23bfd&_nc_zt=14&_nc_ht=scontent-iad3-2.xx&_nc_gid=AFrLIY42caLFXZCASaNN9DB&oh=00_AYBQhfIQd-j8GmA7xcI2Y60ZP4ypSETYy9FYfXfh1aQ0-g&oe=67582813 |
| Page Entity Type | PERSON_PROFILE |
| Instagram Actor Name | |
| Instagram Profile Pic Url | |
| Instagram Url | |
| Instagram Handle | |
| Body | Join us on the latest episode of the Global Hemophilia Report, where Senior Advisor Dr. Donna DiMichele leads an in-depth discussion on FVIII inhibitors—a critical complication in Hemophilia A. Featuring esteemed experts like Dr. Kathleen Pratt, Dr. David Lillicrap, Dr. Bhavya Doshi, Dr. Carol Miao, Glaivy Batsuli, and Dr. Radek Kazmarek, this episode dives deep into the complexities of immune responses, gene therapy, and innovative treatments such as emicizumab. Our experts explore key factors including antigen-presenting cells, B cells, T cells, microbiome effects, and glycans that influence inhibitor development and tolerance. Despite the strides made in treatment, they emphasize the continued need for research in understanding and preventing FVIII inhibitors. Contributors: Senior Advisor: Donna DiMichele, MD Listen, Rate, Review, and Subscribe: https://bit.ly/ghr_podlink Supported through advertising by Sanofi Search for #GlobalHemophiliaReport wherever you get your #podcasts. #hemophilia #haemophilia #bleedingdisorders #clinicalresearch #hematology #GHRpod #bloodstreammedia |
| Branded Content | |
| Current Page Name | Global Hemophilia Report |
| Disclaimer Label | |
| Page Profile Uri | https://www.facebook.com/GlobalHemophiliaReport/ |
| Root Reshared Post | |
| Cta Type | LEARN_MORE |
| Additional Info | |
| Ec Certificates | |
| Country Iso Code | |
| Instagram Branded Content | |
| Statemediarunlabel |